O6.8. GLUTAMATERGIC DYSFUCTION AND TREATMENT RESPONSE IN MINIMALLY TREATED AND CHRONIC SCHIZOPHRENIA PATIENTS

BACKGROUND: Glutamatergic dysfunction as a result of NMDA receptor hypofunction has been implicated in antipsychotic treatment-resistant schizophrenia, however its nature in very early stages and chronic stages of the disease is still unknown. Data on glutamate and treatment response are currently l...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouchlianitis, Elias, Vanes, Lucy, Barry, Erica, Patel, Krisna, Wong, Katie, Porfy, Lilla, Shergill, Sukhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887993/
http://dx.doi.org/10.1093/schbul/sby015.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887993/
http://dx.doi.org/10.1093/schbul/sby015.229

Ejemplares similares